Lyell Immunopharma, Inc.
$8.12
-0.07 (-0.85%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- -24.8%
- 3 Months
- -37.2%
- YTD
- -73.6%
- 1 Year
- -53.3%
- 3 Year annualized
- -36.8%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 79.4%
- Largest decline max drawdown, since Oct 2021
- -97.5%
- Risk-adjusted return Sharpe ratio, 1-year
- -0.56
Own LYEL?
See how LYEL contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.